Literature DB >> 21570887

Review of use of drugs for conditions not included in product characteristics.

A García-Sabina1, R Rabuñal Rey, R Martínez-Pacheco.   

Abstract

Off-label use of medication is common in hospital clinical practice and should be applied together with follow-up of a healthcare treatment protocol and in compliance with a procedure which ensures that the patient is informed and that he or she provides informed consent. A review of the literature on controlling 310 disorders showed that off-label use was indicated for 69 of them (22.3%) with the minimum required scientific evidence. It would be useful for the Pharmacy and Therapeutics Committee to have a list of the disorders that can be controlled using off-label drugs, providing a reference to those disorders which must follow a healthcare treatment protocol. A list of the mentioned characteristics is also useful for the hospital pharmacist for validating prescriptions, as it would provide a reference for assessing prescriptions which at first sight could seem questionable. Finally, this list would be very useful if a search index of all the drugs by disorder were to be included in the Pharmacotherapeutic Guide. It would complement the usual indices which include active ingredients and specialties.
Copyright © 2010 SEFH. Published by Elsevier Espana. All rights reserved.

Entities:  

Mesh:

Year:  2011        PMID: 21570887     DOI: 10.1016/j.farma.2010.06.011

Source DB:  PubMed          Journal:  Farm Hosp        ISSN: 1130-6343


  2 in total

1.  Physician-pharmacist agreement about off-label use of medications in private clinical settings in Baghdad, Iraq.

Authors:  Saad A Hussain; Ashwaq N Abbas; Hasan A Alhadad; Ali A Al-Jumaili; Zainab S Abdulrahman
Journal:  Pharm Pract (Granada)       Date:  2017-08-20

Review 2.  Regulation of Drug Prescribing Information in Latin America and the Caribbean.

Authors:  Mariana Ramírez-Telles; Urimara Argotti-Rodríguez
Journal:  Ther Innov Regul Sci       Date:  2022-04-05       Impact factor: 1.337

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.